Oncorus Alpha and Beta Analysis
| ONCRDelisted Stock | USD 0.04 0.01 14.71% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Oncorus. It also helps investors analyze the systematic and unsystematic risks associated with investing in Oncorus over a specified time horizon. Remember, high Oncorus' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Oncorus' market risk premium analysis include:
Beta 0.58 | Alpha (2.21) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Oncorus |
Oncorus Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Oncorus market risk premium is the additional return an investor will receive from holding Oncorus long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Oncorus. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Oncorus' performance over market.| α | -2.21 | β | 0.58 |
Oncorus Fundamentals Vs Peers
Comparing Oncorus' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Oncorus' direct or indirect competition across all of the common fundamentals between Oncorus and the related equities. This way, we can detect undervalued stocks with similar characteristics as Oncorus or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Oncorus' fundamental indicators could also be used in its relative valuation, which is a method of valuing Oncorus by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Oncorus to competition |
| Fundamentals | Oncorus | Peer Average |
| Return On Equity | -1.25 | -0.31 |
| Return On Asset | -0.32 | -0.14 |
| Current Valuation | 25.71 M | 16.62 B |
| Shares Outstanding | 26.09 M | 571.82 M |
| Shares Owned By Insiders | 12.69 % | 10.09 % |
| Shares Owned By Institutions | 55.29 % | 39.21 % |
| Number Of Shares Shorted | 447.72 K | 4.71 M |
Oncorus Opportunities
Oncorus Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Phio Pharma rises 11 percent on positive data from preclinical study of PH ... - Seeking Alpha | 04/17/2023 |
2 | Oncorus Reports First Quarter 2023 Financial Results and Provides ... - Marketscreener.com | 05/22/2023 |
3 | Oncorus Shares Head for All-Time Low on Cash Flow Concerns | 06/02/2023 |
About Oncorus Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Oncorus or other delisted stocks. Alpha measures the amount that position in Oncorus has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Oncorus Upcoming Company Events
As portrayed in its financial statements, the presentation of Oncorus' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Oncorus' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Oncorus' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Oncorus. Please utilize our Beneish M Score to check the likelihood of Oncorus' management manipulating its earnings.
| 3rd of August 2023 Upcoming Quarterly Report | View | |
| 1st of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 22nd of March 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Oncorus
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Oncorus Stock
If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |